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Background: Recent evidence suggests that psychosocial treatments, particularly
cognitive-behavioral therapy (CBT), are effective interventions for adult attention deficit
hyperactivity disorder (ADHD). The objective of this reviewwas to determine the long-term
efficacy of psychosocial interventions in improving clinically relevant variables, including
ADHD core symptoms, clinical global impression (CGI), and global functioning.
Methods: In total, nine randomized controlled trials and three uncontrolled single-group
pretest-posttest studies were included. The data from these studies were combined
using the inverse variance method. Heterogeneity and risk of bias were assessed.
Subgroup analyses and meta-regressions were performed, to determine the influence of
different potential moderator variables (risk of bias, medication status, follow-up length,
therapy type and setting, and control group type) on effect size (ES) estimates.
Results: Up to 680 of a total of 1,073 participants assessed pre-treatment were retained
at follow-up. Treatment groups showed greater improvement than control groups in
self-reported total ADHD symptoms, inattention, and hyperactivity/impulsivity, in addition
to CGI and global functioning. Blind assessors also reported a large ES in within-subject
outcomes. Studies using dialectical behavioral therapy (DBT) in a group setting, with
active control matching, and that were rated as having an unclear risk of bias, achieved
significantly lower ES estimates for most outcomes. Treatment effectiveness, according
to the CGI measure, and global functioning were significantly increased when the
percentage of medicated participants was greater.
Conclusions: Our results indicate that the post-treatment gains reported in previous
reviews are sustained for at least 12 months. Nevertheless, these results must be
interpreted with caution, because of a high level of heterogeneity among studies and
the risk of bias observed in the majority of outcomes. Thus, these findings indicate that
psychological interventions are a highly valuable and stable clinical tool for the treatment
of core symptoms and global functioning in adults with ADHD.
Keywords: meta-analysis, adult ADHD treatment, psychosocial treatment, long-term efficacy, cognitive-
behavioral therapy, dialectical-behavior therapy, mindfulness-based cognitive therapy
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INTRODUCTION
Rationale
ADHD is a childhood-onset neurodevelopmental disorder
characterized by developmentally inappropriate levels of
inattention, hyperactivity, and impulsivity (American Psychiatric
Association., 2013). The disorder affects 2.5–2.8% of the adult
population (Simon et al., 2009; Fayyad et al., 2016), and is
associated with significant impairment in academic (Kuriyan
et al., 2013; Voigt et al., 2017), health (Nigg, 2013; Brevik et al.,
2017), occupational (Kirino et al., 2015; Hechtman et al., 2016),
and social (Das et al., 2012) domains. It is also related to the
development of other comorbid conditions such as learning
disorders (Knouse et al., 2012; Duda et al., 2015); oppositional
defiant disorder (Reimherr et al., 2013); anxiety disorders
(Cadman et al., 2016); substance use disorder (Capusan et al.,
2016); and borderline personality disorder (Matthies and
Philipsen, 2014), among others. In addition, the risk of suicide is
significantly higher in adults with ADHD (Barbaresi et al., 2013),
even after controlling for other comorbid disorders (Stickley
et al., 2016). Thus, the need to treat ADHD is evidenced by
the significant impact that the disorder has on the different
areas of adult life. Pharmacotherapy is the first-line treatment
for adults with ADHD with either moderate or severe level of
impairment (National Institute for Health and Care Excellence,
2008). Stimulant drugs exhibit a moderate-to-large effect size
(ES) (standardized mean difference [SMD] = 0.72) on ADHD
symptoms (Castells et al., 2011; Epstein et al., 2014), while
for non-stimulant drugs (e.g., atomoxetine), ES is low-to-
moderate (SMD= 0.39) (Faraone and Glatt, 2010). Additionally,
pharmacotherapy has long-term beneficial effects (Fredriksen
and Peleikis, 2016). Nevertheless, drug therapy has significant
limitations, since it is often associated with adverse effects and
a high dropout rate (Cunill et al., 2016), and many individuals
only exhibit partial responses (Wilens et al., 2002). Moreover,
a combination of both psychosocial and medication treatment
has proven more effective than drugs alone (Safren et al., 2005;
Emilsson et al., 2011; Young et al., 2015), and is also associated
with improved treatment adherence (Cunill et al., 2016).
Although they share therapeutic components, different
psychosocial approaches have been designed or adapted for
the treatment of adult ADHD, including: (1) Cognitive-
behavioral therapy (CBT), which aims to develop behavioral
strategies to compensate for core neuropsychiatric deficits and
to change dysfunctional thinking styles (Safren et al., 2004);
(2) Dialectical behavioral therapy (DBT), which is a CBT-
based approach initially developed by Linehan (1993) for the
treatment of borderline personality disorder, and was later
modified to address the specific needs of adult ADHD. DBT
aims to both promote the acceptance and validation of ADHD-
related symptoms, and teach the skills required for change
and self-management (Hesslinger et al., 2002); (3) Mindfulness
meditation training, which is a type of meditative technique that
emphasizes a compassionate and non-reactive attitude toward
one’s thoughts, emotions, and body state (Zylowska et al., 2008),
and mindfulness-based cognitive therapy (MBCT), which is a
combination of CBT and mindfulness; (4) Cognitive training
(CT), which is premised on the notion that the key brain
networks involved in ADHD can be strengthened, and the
cognitive processes they subserve improved, through controlled
exposure to information processing tasks (Vinogradov et al.,
2012); and (5) Neurofeedback (NFB), which is a variant of
EEG biofeedback that aims to promote self-regulation of specific
brain activity patterns in an operant conditioning paradigm
(Hammond, 2007).
Previously meta-analytic reviews have found that psychosocial
interventions are effective at the end of the treatment, with
moderate-to-large ES estimates on inattention and total ADHD
symptoms and also on clinical global impression (CGI) and
global functioning, which were reduced to small-to-moderate
ES estimates for comparisons with active control groups, and
only increased to large when within-subject data were analyzed,
with small-to-moderate effects on hyperactivity/impulsivity
symptoms (Linderkamp and Lauth, 2011; Cairncross and Miller,
2016; Jensen et al., 2016; Young et al., 2016; Knouse et al.,
2017) (Table 1). Their results also varied depending on the
source of information, since some reviews suggested that no
significant effect was achieved (Jensen et al., 2016), while others
found a moderate ES, according to blind evaluators (Knouse
et al., 2017). In conclusion, psychosocial interventions have
been found to improve ADHD symptoms and other clinically
relevant variables in adults with ADHD at the end of treatment.
However, none of these reviews examined whether the gains
were maintained months after the end of treatment. In a
disorder that tends to be chronic such as ADHD, the stability
of improvements is one of the key features of an intervention,
since the psychotherapy is aimed at the long-term modification
of certain pathological behaviors and thoughts that cause nuclear
symptoms to generate a greater impairment. Likewise, the
efficacy of different therapy options (e.g., CBT, DBT, MBCT,
etc.) have not been compared and several recently published
significant studies have not been included in some of these
reviews.
A number of studies have evaluated the efficacy of such
interventions in the long-term, and demonstrated that it is
maintained from 3 to 12 months after the end of the treatment
(Safren et al., 2010; Salakari et al., 2010; Emilsson et al.,
2011; Pettersson et al., 2014; Fleming et al., 2015; Salomone
et al., 2015; Young et al., 2015; Cherkasova et al., 2016; Gu
et al., 2017; Nasri et al., 2017), although the magnitudes of
the reported effects are heterogeneous. The largest clinical
trial so far published in the field found that groups receiving
psychosocial therapy had superior outcomes to active control
groups at follow-up only in the CGI measure, but not in
ADHD symptoms (Philipsen et al., 2015). Other studies have
also reported the maintenance of therapeutic achievements,
according to the CGI measure (Safren et al., 2010; Young
et al., 2015). Moreover, improvements in global functioning are
also maintained, according to some studies (Emilsson et al.,
2011; Fleming et al., 2015; Young et al., 2015; Morgensterns
et al., 2016), but not others (Pettersson et al., 2014). To
date, no meta-analytical review of the long-term efficacy
of psychosocial treatment in adults with ADHD has been
performed.
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Design Treatment Control Main results
Cairncross and Miller,
2016
Until 2014 3 RCT (n = 3) MBCT (n = 3) Waitlist (n = 3) ADHD symptoms:
SMD = −0.91 95% CI (−1.41 to −0.42); I2 = 89.73
Jensen et al., 2016 Until 2014 2 RCT (n = 2) CBT (n = 2) TAU (n = 2) ADHD symptoms (self-reported):
SMD = −1.00 95% CI (−1.50 to −0.50)
ADHD symptoms (clinician-reported):
SMD = −0.60 95% CI (−1.30 to 0.10)




All considered CBT Active (n = 5)
Not active
(n = 13)
ADHD symptoms (self-reported and assessor
reported) from within-subject data:
SMD = 1.00 95% CI (0.84 to 1.16); SMD = 1.40
95% CI (1.10 to 1.71)
ADHD symptoms (self-reported) vs. control:
SMD = 0.65 95% CI (0.44 to 0.86)
CGI (assessor-reported) from within-subject data:
SMD = 1.12 95% CI (0.79 to 1.43)
Functioning (self-reported) from within-subject data
and vs. control:
SMD = 0.73; 95% CI (0.46 to 1.00); SMD = 0.51
95% CI (0.23 to 0.79)
Linderkamp and Lauth,
2011




CBT (n = 8)
DBT (n = 2)
Psycho-education
(n = 1)
Active (n = 1)
Waitlist (n = 3)
All outcomes averaged:
SMD = 0.84 95% CI (0.64 to 1.04)
Young et al., 2016 Until 2014 9 RCT (n = 8) CBT (n = 8) Active (n = 4)
Waitlist (n = 5)
ADHD symptoms (CBT vs. Wait list):
SMD = 0.76 95% CI (0.21 to 1.31); I2 = 63%
ADHD symptoms (CBT vs. Active control):
SMD = 0.43 95% CI (0.14 to 0.71); I2 = 31%
Objectives
Themain purpose of this review was to investigate if the observed
post-treatment efficacy of psychological interventions on the
nuclear symptoms of adults with ADHD was maintained from
3 months onwards after their termination. Similarly, the study
aimed to ascertain if the post-treatment gains in CGI and global
functioning were also sustained. Finally, we sought to explore
how different variables (e.g., outcome measure source, within-
study risk of bias, therapy type and setting, control group type,
medication status, and follow-up length) moderate ES estimates
for each outcome.
Research Questions
This study aims to answer the following research questions:
A) Are therapeutic gains from the psychosocial treatments
maintained at follow-up in adults with ADHD?
B) To what extent do variables, such as therapeutic approach,
medication status, or type of control group (among others),
influence the maintenance of achievements?
METHODS
This review adheres to the Preferred Reporting Items for
Systematic Reviews and Meta-analyses (PRISMA) guidelines
(Liberati et al., 2009). A detailed checklist can be seen in the
Supplementary Table 1.
Study Design
Randomized controlled trials (RCTs) and uncontrolled single-
group pretest-posttest studies were included in the analysis.
Although uncontrolled single-group pretest-posttest studies raise
issues of internal validity, some authors in the meta-analytic area
advocate their use in systematic reviews when there are few RCTs
in a given field. For example, Hunter and Schmidt (2004) and
Petticrew and Roberts (2005) supported the use of within-group
designs in a meta-analysis when there are ethical or other reasons
that hinder or prevent the use of control groups.
Participants, Interventions, Comparators,
and Outcomes Included
The following eligibility criteria were used in this review, detailed
using the PICO approach (O’Connor et al., 2011).
Participants
Participants were required to meet the DSM-IV (4th ed., text.
rev., American Psychiatric Association., 2000) or DSM-5 (5th
ed., American Psychiatric Association., 2013) criteria for ADHD
in adults. The studies should specify a detailed protocol of the
diagnostic assessment. All participants had to be over 18 years
old. Studies using a sample in which participants presented
psychotic disorders, bipolar disorder, severe active addictions
at the time of treatment, or clinically significant personality
disorders (Axis II) were excluded; however, the existence of other
Axis I disorders (mood disorders, anxiety disorders, etc.) was not
a reason for exclusion.
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Intervention
Studies in which at least one of the experimental groups received
a psychosocial treatment specifically designed for ADHD, either
supported by pharmacotherapy or not, were included. Such
treatment had to be adequately described and detailed.
Comparisons
For the between-groups outcomes, studies in which at least
one of the groups (control group) did not receive a specific
psychotherapy for ADHD were included. The control group
could be: (1) An active control group, in which participants
received support from a therapist, in a group or individual non-
directive sessions in which no specific strategy was discussed,
or even non-specific interventions for ADHD such as relaxation
training; (2) A treatment as usual (TAU) group, in which all
participants received the usual treatment, which included both
pharmacological and potentially also some non-pharmacological
treatments; (3) A waiting-list group, in which participants were
waiting without receiving any psychosocial treatment, although
some, but not all, participants received pharmacotherapy.
Outcomes
Studies were required to perform a follow-up assessment at
least 3 months after the end of the treatment, which had to
include an ADHD symptoms severity scale, since this was used
as the primary outcome measure for our review. CGI and global
functioning were secondary outcomes. CGI (National Institute
of Mental Health, 1985) is a three-item observer-rated scale that
measures illness severity, global improvement or change, and
therapeutic response. It has been proven as a robust measure
of efficacy in clinical trials; therefore, it has been widely used
in many treatment evaluation studies. The global functioning
outcome provides a measure of the impact that symptoms have
on daily functioning in the vital domains (e.g., social, familial,
work, personal, and academic, among others). Instruments, such
as the Sheenan Disability Scale (Sheenan et al., 1996) or the
RATE-S (Young and Ross, 2007) were included in that outcome
category.
Systematic Review Protocol
In accomplishing this systematic review, no previous protocol
was carried out.
Search Strategy
A systematic literature search was performed in MEDLINE (via
PubMed) and Scopus. No date limit was established. The last
search was conducted on September 4, 2017. The search terms
used are detailed in Supplementary Table 2. In addition, reference
lists of retrieved relevant articles were screened.
Data Sources, Study Selection, and Data
Extraction
The selection process is illustrated in Figure 1. After removing
duplicates, the first author conducted a screening search of
relevant articles, based on reading the title and abstract. Then, the
two first authors independently applied the eligibility criteria to
themethods section of the articles, which were previouslymasked
FIGURE 1 | Selection process diagram.
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by a third researcher. Agreement between the two researchers was
acceptable (κ = 0.81). Inconsistencies between the assessors were
solved by consensus. The final selection of the studies was based
on reading the full-text articles.
Data were extracted and coded in a spreadsheet so that all
study characteristic items described in the Cochrane Handbook
were covered (Higgins and Green, 2011). This sheet was pilot-
tested with five studies, to improve its fit to the sample
characteristics. Data extraction and coding were performed
independently by the two first authors. The codebook can be
requested from the corresponding author. Kappa coefficients of
inter-rater agreement were excellent for qualitative moderator
variables (average κ = 0.88; range = 0.75–0.93), as well as for
continuous moderator variables (average intra-class correlation
r = 0.95; range = 0.91–1.0). Disagreements were resolved by
consensus. Four authors were contacted to request additional
information. All of them responded, and data were provided
by three of them. To reduce bias, data in included studies were
searched for duplicates.
The following data were extracted from each study (Table 2):
(1) methodological characteristics: study design, sample size at
every assessment point, and follow-up length; (2) participant
characteristics: percentage of participants receiving ADHD
medication; (3) intervention characteristics: type of therapy,
therapy setting, and number of sessions; (4) comparison group
characteristics: control group type; (5) outcomes: total ADHD
symptoms, inattention and hyperactivity/impulsivity symptoms,
CGI, and global functioning; and (6) outcome characteristics:
measure source (self-rated or blind assessor-rated) for all
outcomes.
Data Analysis
For data analysis, Review Manager software (version 5.3)
from the Cochrane Collaboration and Comprehensive Meta
Analysis (version 3.3.070) were used. Long-term reduction in
the severity of inattention, hyperactivity/impulsivity, and total
ADHD symptoms were considered the primary outcomes,
while CGI and global functioning were secondary outcomes.
TABLE 2 | Summary of characteristics of included studies.






























17/16 16/16 70.61/18.83 DBT Combined 8 Waitlist Self-report 3 Global functioning
Gu et al.,
2017
30/26 28/26 71.42/72.91 MBCT Individual 6 Waitlist Self-report 3 –
Morgensterns
et al., 2016
98 58 74.73 DBT Group 14 – Self-report 3 –
Nasri et al.,
2017
18 18 72 CBT+DBT Group 14 – Self-report 6 –
Pettersson
et al., 2014
14/18 11/0 42.92/50 CBT–G Group 10 Waitlist Self-report 6 Global functioning
Philipsen
et al., 2015













29 25 66 CBT Group 10-11 – Self-report 6 –
Salomone
et al., 2015
24/27 15/14 33.33/22.20 BFB Individual N/E Active Self-report 3 –
Young et al.,
2015
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For the between-group (psychosocial treatments vs. control
groups) outcomes, the effect size index was defined as the
difference between the average pretest-follow-up change of the
experimental and control groups, divided by a pooled estimate of
the pretest standard deviations of the two groups. In addition,
a correction factor for small samples sizes was also applied
(Morris, 2008; see Supplementary Figure 1). For within-subject
(pretest to follow-up) single-group studies, the effect size was
defined as the average pretest-follow-up change, divided by the
pretest standard deviation, and with a correction factor for
small sample sizes (Morris, 2000; see Supplementary Figure 2).
For estimating the variances of both effect size indices,
the Pearson correlation coefficient between the pretest and
follow-up measures must be available. As this figure was not
reported in the studies, a value of 0.70 was assumed for
r, as recommended by Rosenthal (1991). Following the rule
of thumb suggested by Cohen (1988), ES values of 0.20,
0.50, and 0.80 were considered small, moderate, and large,
respectively.
The results of individual studies, weighted by their inverse
variance, were combined for each outcome. A random-effects
model was chosen because of a suspicion of a high heterogeneity
between the studies. A 95% confidence interval (CI) was
calculated for each outcome. The consistency of effect sizes
was assessed using the I2 index (Higgins et al., 2003), which
describes the percentage of total variation across studies that is
due to heterogeneity, rather than chance. I2 values of 25, 50, and
75% can be interpreted as reflecting low, moderate, and high
heterogeneity, respectively (Higgins et al., 2003).
To determine the internal validity of each study, the risk of
bias was assessed by the first author, covering the items described
in The Cochrane Collaboration’s tool for assessing risk of bias
(Higgins et al., 2011): (a) the adequacy of randomization and
concealment of allocation (selection bias), where a comparison
group was available; (b) the blinding of the outcome assessors
(blinding of the therapists could not be assessed in studies that
evaluated psychosocial treatments); (c) the incomplete outcome
data (attrition bias); (d) the selective reporting of the outcomes
(reporting bias); and (e) the medication stabilization (other
sources of bias). This assessment was supervised by the second
author and discrepancies were resolved by consensus. Studies
were not excluded based on the result of the evaluation of the
risk of bias, but they were divided into subgroups (high, unclear,
or low risk of bias) and sensitivity analyses were performed to
determine the influence of this variable on ES estimates.
Publication bias was assessed by visually examining the
asymmetry in the funnel plots of each outcome and conducting
the trim-and-fill method (Duval and Tweedie, 2000). This test
trims the asymmetric studies from the right-hand side to locate
the unbiased effect (in an iterative procedure), and then fills
the plot by re-inserting the trimmed studies on the right, as
well as including their imputed counterparts to the left of the
mean effect. In addition, the Egger test (Egger et al., 1997) for
testing the asymmetry of funnel plots was applied. This test
assesses bias using the precision of each ES (the inverse of the
standard error) to predict the standardized effect (ES divided by
the standard error). Finally, the Fail-safe N (Rosenthal, 1979)
was also calculated, which is the number of additional “negative”
studies (with a null effect) that would be needed to increase the
P-value for the meta-analysis to above 0.05.
Sub-group analyses (chi-square tests) were performed for
each outcome, to assess the impact of the following categorical
variables on ES estimates: (i) risk of bias in individual studies; (ii)
therapy type; (iii) therapy setting; (iv) outcome measure source;
(v) and control group type. Additionally, a meta-regression was
carried out for each outcome with continuous variables, such as
the percentage of participants in the experimental group under
pharmacological treatment and the follow-up length, to ascertain
the extent to which they predicted the ES.
RESULTS
Study Selection
From 236 records, nine RCTs and three uncontrolled single-
group pretest-posttest studies were identified and included
in the quantitative review, based on the reading of full-
text reports (Figure 1). Two RCTs were excluded from
between-groups, but included in within-subject meta-analyses,
because the control group was not assessed at follow-up
(Pettersson et al., 2014) and all groups received specific
ADHD psychotherapy (Cherkasova et al., 2016). Thus,
finally, seven and 12 studies were included in the between-
groups and within-subject meta-analyses, respectively. The
characteristics of the included studies are presented in Table 2,
and a list of excluded studies and the reasons for exclusion
are detailed in Supplementary Table 3. For the study by
Philipsen et al. (2015), each treatment group was compared
with the equivalent control group, based on medication
status.
Participants
Up to 680 of 1,073 participants assessed pre-treatment were
retained at follow-up. On average, 50.72% of participants were
male, age was 34.41 years, and 63.70% of participants were taking
medication for ADHD during the treatment.
Intervention
Half of the treatment groups underwent CBT (50%) and 25%
DBT; while MBCT, Biofeedback (BFB), or a combination of CBT
and DBT were applied for 8.33%. On average, 11.42 sessions
were conducted. Group and individual treatments were delivered
in 41.66 and 25% of studies, respectively, while both types of
treatment were combined in 33.33%.
Comparison
An active control group was used in 42.92% of the studies, while
28.64% compared the intervention to a TAU or waitlist group.
Outcomes
Blinded assessors of the primary outcome measure were used in
33.33% of studies, while the remainder used only self-reported
measures.
Frontiers in Psychology | www.frontiersin.org 6 May 2018 | Volume 9 | Article 638
López-Pinar et al. Long-Term Psychotherapy Adult ADHD
Synthesized Findings
All Treatment vs. all Control Groups
Combining all treatment groups, significant differences were
found between the subjects that received a psychosocial
intervention and those in the combined control groups in
self-reported total ADHD symptoms [χ2
(1)
= 7.95, p < 0.01],
inattention [χ2
(1)
= 6.34, p= 0.01], and hyperactivity/impulsivity
[χ2
(1)
= 10.90, p < 0.01], as well as in CGI [χ2
(1)
= 5.66,
p = 0.02], and global functioning [χ2
(1)
= 5.60, p = 0.02]
outcomes, in favor of the treated groups (Figure 2). Although
the treated groups obtained a higher ES, differences in blind
assessor rated total ADHD symptoms [χ2
(1)
= 2.05, p = 0.15],
inattention [χ2
(1)
= 0.01, p= 0.91], and hyperactivity/impulsivity
[χ2
(1)
= 2.37, p= 0.12] outcomes were not significant (Figure 3).
Between-Group Outcomes
Taking into account only data from the RCTs, treatment
groups showed greater improvement than control groups in
self-reported total ADHD symptoms (SMD = 0.71; 95%
CI [0.22–1.21]), inattention (SMD = 0.64; 95% CI [0.23–
1.01]), and hyperactivity/impulsivity (SMD = 0.66; 95%
CI [0.18–1.14]) outcomes, for which ES estimates were
medium-to-large (Table 3; Figures 4–6). In contrast, blind
assessors reported small-to-moderate ES on total ADHD
symptoms (SMD = 0.40; 95% CI [−0.06 to 0.85]), and
hyperactivity/impulsivity (SMD= 0.28; 95% CI [−0.13 to 0.70]),
and a small ES on inattention (SMD = 0.14; 95% CI [−0.29 to
0.58]) outcomes, but with confidence intervals including zero.
Treatment efficacy measured by CGI was small-to-moderate
(SMD = 0.44; 95% [0.14–0.74]) (Figure 7). Finally, a moderate-
to-large ES (SMD= 0.76; 95% [0.23–1.28]) was achieved for self-
reported global functioning (Figure 8). High heterogeneity was
observed for all outcomes (Table 3).
Within-Subject Outcomes
The within-subject treatment ES estimates on all ADHD
symptom outcomes were large, both for self-reported (SMD =
1.09; 95% CI [0.85–1.32] for total ADHD symptoms) and blind
assessed (SMD = 1.18; 95% CI [0.90–1.46] for total ADHD
symptoms) measures, except for hyperactivity/impulsivity
symptoms as reported by blind assessors (SMD = 0.67; 95%
CI [0.49–0.85]) (Table 3, Figures 9–11). The ES on CGI
outcome was also large (SMD = 1.20; 95% CI [0.93–1.48])
FIGURE 2 | Forest plot for all treatment and control groups on self-reported total ADHD symptoms outcome.
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FIGURE 3 | Forest plot for all treatment and control groups on blind assessor-reported total ADHD symptoms outcome.
(Figure 12), while that on global functioning was moderate-to-
large (SMD = 0.58; 95% CI [0.25–0.92]) (Figure 13). I2 indices
indicated greater homogeneity than for the between-groups
outcomes (Table 3). Heterogeneity was zero and low for the
blind assessor-rated inattention and hyperactivity/impulsivity
outcomes, respectively, and high for self-rated total ADHD
symptoms and global functioning, whereas it was moderate for
the remaining outcomes.
Risk of Bias
All self-rated outcomes were rated with a high risk of bias, while
the risk of bias summary for the blind assessor-rated outcomes
was classified as unclear (Supplementary Tables 4–8). Only one
study was assessed to have a low risk of bias for all outcomes,
except for global functioning.
Publication bias indicators were identified for the between-
groups outcomes. The results of the Egger’s test were significant
or marginally significant for total ADHD symptoms, inattention,
and hyperactivity/impulsivity outcomes (Supplementary
Table 9). Use of the Trim and Fill method decreased the
confidence interval to below zero after trimming some studies
in the self-reported and blind assessor-rated total ADHD
symptoms and self-reported inattention outcomes. In contrast,
between-groups CGI and global functioning outcomes are
likely robust to publication bias. Similarly, fail-safe N results
for self-reported total ADHD symptoms, inattention, and
hyperactivity/impulsivity outcomes indicated that a number
of studies between six and eight times higher than those
included would be necessary for the estimated effect to be
null.
Regarding within-subject outcomes, although the results of
the Egger’s test were significant for blind assessor-rated total
ADHD symptoms, inattention, and hyperactivity/impulsivity
outcomes, the confidence interval of the Trim and Fill method
adjusted estimates remained above zero (Supplementary Table
10). In addition, the fail-safe N for those outcomes ranged
from 42 to 157. No indicators of publication bias were
apparent for self-reported total ADHD symptoms, inattention,




Significant differences were found for between-groups total
ADHD symptoms [χ2
(2)
= 11.74, p < 0.01], inattention [χ2
(2)
=
31.22, p < 0.01], and hyperactivity/impulsivity [χ2
(2)
= 31.40,
p= 0.01] (Supplementary Table 11), as well as for within-subject
inattention [χ2
(2)
= 8.23, p = 0.02] (Supplementary Table 12). ES
estimates were significantly lower for studies rated as having an
unclear risk of bias for all of these outcomes.
Therapy
DBT studies achieved significantly, or marginally significantly,
lower ES estimates on between-groups total ADHD symptoms
[χ2(3) = 16.47, p < 0.01], inattention [χ2(3) = 8, p =
0.05], and hyperactivity/impulsivity [χ2(3) = 32.96, p < 0.01]
(Supplementary Table 11), on within-subject total ADHD
symptoms [χ2(3) = 7.42, p = 0.06] (see Supplementary Table
12), and on between-groups CGI [χ2(1) = 6.87, p < 0.01] and
global functioning [χ2(1) = 5.36, p = 0.02]. Biofeedback studies
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TABLE 3 | Standardized mean differences (SMD), 95% confidence intervals, heterogeneity analyses, and risk of bias for between-groups and within-subject outcomes.
Between-groups outcomes Within-subject outcomes
Outcome Rater Studies N SMD 95% CI Hetero-
geneity
(I2)








8 513 0.71 0.22 to 1.21 93% High 14 409 1.09 0.85 to 1.32 77% High
Blind
assessor





7 446 0.64 0.21 to 1.07 88% High 8 243 1.20 0.96 to 1.44 53% High
Blind
assessor






6 406 0.69 0.22 to 1.16 90% High 7 227 0.83 0.59 to 1.08 64% High
Blind
assessor











3 120 0.76 0.23 to 1.28 67% High 4 102 0.58 0.25 to 0.92 72% High
FIGURE 4 | Forest and funnel plots for between-groups total ADHD symptoms outcome.
generated significantly lower ES estimates on within-subject
hyperactivity/impulsivity symptoms [χ2(3) = 17.10, p < 0.01].
Treatment Setting
ES estimates were significantly, or marginally significantly, lower
in studies using a group treatment setting on between-groups and
within-subject total ADHD symptoms [χ2(2) = 36.68, p < 0.01
and χ2(2) = 15.83, p < 0.01, respectively], inattention [χ2(2) =
29.21, p < 0.01 and χ2(2) = 5.83, p = 0.05, respectively], and
hyperactivity/impulsivity [χ2(2) = 24.83, p < 0.01 and χ2(2) =
5.75, p = 0.06, respectively] (Supplementary Tables 11, 12),
as well as on between-groups CGI [χ2(2) = 6.90, p = 0.03]
and within-subject global functioning [χ2(1) = 8.92, p < 0.01]
outcomes, while the ES on the within-subject CGI outcome
was significantly higher than that for the individual setting
[χ2(2) = 6.25, p= 0.04].
Measure Source
A significantly lower ES on the within-subject inattention
outcome was found for blind assessor measurement [χ2(1) = 3.88,
p = 0.05], while no significant differences were found for the
remaining outcomes (Supplementary Tables 11, 12).
Control Group
Active control-matched studies generated a significantly, or
marginally significantly, lower ES on total ADHD symptoms
[χ2(2) = 5.71, p= 0.06], inattention [χ2(2) = 11.61, p < 0.01], and
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FIGURE 5 | Forest and funnel plots for between-groups inattention symptoms outcome.
FIGURE 6 | Forest and funnel plots for between-groups hyperactivity/impulsivity symptoms outcome.
hyperactivity/impulsivity [χ2(2) = 16.46, p < 0.01], as well as for
global functioning [χ2(1) = 5.36, p= 0.02] (Supplementary Table
11).
Follow-Up Length
None of the meta-regressions were significant with respect to this
variable, with a confidence level of 95% (Supplementary Tables
13, 14).
Percentage of Participants on Medication
A higher percentage of participants on medication predicted
higher ES on between-groups and within-subject CGI
(Coefficient = 0.01, 95% CI [0.00–0.01], p = 0.02; Coefficient
= 0.01, 95% CI [0.00–0.01], p = 0.01) and on within-subject
global functioning and total ADHD symptoms (Coefficient =
0.02, 95% CI [0.00–0.04], p = 0.01; Coefficient = 0.01, 95%
CI [0.00 to 0.001]), while no significant meta-regressions were
found for the remaining outcomes (Supplementary Tables
13, 14).
DISCUSSION
Summary of Main Findings
Psychosocial treatments have exhibited post-treatment efficacy
for both core and other symptoms in adults with ADHD
(Cairncross and Miller, 2016; Jensen et al., 2016; Young et al.,
2016; Knouse et al., 2017); however, no previous studies have
systematically explored whether therapeutic improvements are
maintained at follow-up assessment. In this study, a meta-
analytic review was conducted to determine if treatment gains
were sustained between 3 and 12 months after the end of
treatment, for both core ADHD symptoms and other clinically
relevant measures, and to what extent different moderator
variables influence this maintenance.
Our results indicate that self-reported post-treatment gains
were effectively sustained for at least 12 months. Inattention,
hyperactivity/impulsivity, and total ADHD symptoms, as well
as global functioning, were significant improved in treated
compared with control groups, as reported by participants, with
medium-to-large ES estimates. Improvements in CGI measure
were also maintained. These results support the validity of those
obtained in previous post-treatment meta-analyses (Cairncross
and Miller, 2016; Jensen et al., 2016; Young et al., 2016; Knouse
et al., 2017). Nevertheless, according to blind assessors, between-
group improvements in ADHD symptoms reported by previous
meta-analytic reviews did not persevere over time.
On the other hand, the results provide further empirical
support for the within-subject improvement. This study found
that the post-treatment ES estimates on within-subject CGI,
total ADHD symptoms, and inattention reported by Knouse
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FIGURE 7 | Forest plot for between-groups CGI outcome.
FIGURE 8 | Forest plot for between-groups global functioning outcome.
et al. (2017) remained large at follow-up, for both blinded
and self-reported measures, while the ES on global functioning
continued to be moderate-to-large. One interesting finding
is that the self-reported within-subject treatment effects on
hyperactivity/impulsivity symptoms increased from moderate-
to-large to large at follow-up.
Concerning the comparison between the different therapeutic
options, DBT and Biofeedback are not as effective as CBT on
the key outcome measures. Although MBCT reached a large
ES on all ADHD symptom outcomes, evidence came only
from one study. In addition, when CBT studies were isolated,
the ES estimates for between-groups blind assessor-rated total
ADHD symptoms became significant (SMD = 0.76; 95% CI
[0.45–1.06]) and those for CGI increased to moderate-to-large
(SMD = 0.72; 95% CI [0.44–0.99]). Furthermore, the majority
of studies for which data were included for most outcomes
used CBT. All these findings suggest that CBT could be the
psychosocial intervention with the most long-term empirical
support for the treatment of ADHD in adults. CBT is based
on the premise that underlying neurobiological impairments
hinder adults with ADHD from acquiring and using adaptive
compensatory strategies (i.e., use of higher-level organization
and planning strategies), which maintains and exacerbates
the core symptoms and further contributes to a chronic
functional impairment persisting since childhood (Knouse and
Safren, 2010). That impairment, together with a negative social
feedback, can lead to the development of maladaptive negative
cognitions and beliefs that decrease motivation and increase
avoidance behavior and mood disturbance, thus reinforcing the
cycle. This CBT model of ADHD was supported by recent
research findings, which found that adult ADHD is significantly
related to dysfunctional cognitions, cognitive distortions and
maladaptive coping strategies of escape-avoidance (Mitchell
et al., 2013; Torrente et al., 2014; Strohmeier et al., 2016).
Thus, CBT is aimed at the acquisition and especially the
maintenance of compensatory skills, and also at the development
of cognitive strategies to challenge the cognitive distortions,
so that core neurobiological deficits do not translate as
frequently into functional impairments (Safren et al., 2004).
Therefore, a possible explanation for the stability of the
improvements found on the CBT subset of studies might
be that individuals with ADHD were able to learn and
integrate the compensatory behavioral skills and the cognitive
strategies into daily life, so that the changes were sustained
throughout the time, despite the fact that treatment had
ended.
Another notable finding from the moderator analyses was
that, when compared, the individual setting was more effective
than group treatment on the main outcomemeasures. This result
could be explained by the fact that individual treatment is better
suited to the specific needs of each individual, and that probably
each participant received more attention from the therapist than
in a group setting, which might increase the effectiveness of the
treatment.
With respect to the source of the measures, on the one
hand, only self-reported ADHD core symptom outcomes
showed improvements, while blinded assessment did not,
when treatment groups were compared to control groups.
This finding could be an indicator of the presence of a
significant placebo effect on control groups, which obtained
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FIGURE 9 | Forest and funnel plots for within-subject total ADHD symptoms outcome.
FIGURE 10 | Forest and funnel plots for within-subject inattention symptoms outcome.
a significant ES on the main outcome measures. On the
other hand, some other significant results supporting blind-
reported efficacy were obtained. First, CGI is a blinded measure,
and between-groups treatment effect was small-to-moderate
as measured by this instrument, while within-subject change
was large. Second, a large effect was reached on within-
subject blinded ADHD symptom outcomes. Third, moderator
analyses only detected significant differences on the basis of
the measure source (blinded vs. self-reported) on the within-
subject inattention outcome, while the other comparisons
were not significant. Forth, several individual studies found
a significant long-term effect as reported by blind assessors
(Safren et al., 2010; Emilsson et al., 2011; Young et al.,
2015).
Meta-regression results indicate that follow-up length (from
3 to 12 months) does not predict treatment efficacy, which
further supports the stability of the gains. In addition, the
results indicate that medication is a factor that influences
treatment effectiveness, according to the CGI measure, which
increased when the percentage of medicated participants
was greater, supporting the conclusions of several previous
RCTs (Philipsen et al., 2015; Cherkasova et al., 2016). This
finding offers empirical support for the combination of
psychotherapy, particularly CBT, and pharmacotherapy
as the most effective treatment option for adults with
ADHD.
Studies using DBT, in a group setting, with active control-
matching, and that were rated with an unclear risk of bias,
achieved significantly lower ES in the majority of outcomes.
This finding could be caused mainly by the study by Philipsen
et al. (2015), which had considerable weight in the meta-analyses
due to its large sample size since it was present in all these
subgroups.
Thus, our findings indicate that there is self-reported
evidence that the psychosocial interventions, particularly CBT
in an individual setting, specifically improve ADHD core
symptoms and global functioning until at least a year after
the end of treatment, in comparison with control groups.
Additionally, within-subject improvements are also maintained,
even according to blind evaluators. These long-term gains further
support the usefulness of psychosocial treatments for addressing
adult ADHD. Nevertheless, our results must be interpreted
with caution because of the high heterogeneity observed in the
majority of the outcomes.
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FIGURE 11 | Forest and funnel plots for within-subject hyperactivity/impulsivity symptoms outcome.
FIGURE 12 | Forest plot for within-subject CGI outcome.
Limitations and Future Research
The limitations of the present review require consideration
to ensure appropriate interpretation of the findings. First, the
statistical power and moderator analyses are limited by the small
number of available studies. Second, a high risk of bias was
determined for many of the outcomes. Self-reported outcome
measures, the use of unblinded outcome assessors, lack of
accuracy in the description of dropouts (and the reasons for
these), and allocation/randomization processes were the main
sources of bias. Third, we identified indicators of publication
bias for some outcomes. The results of the Egger test were
significant for all between-group and blind assessor-rated within-
subject outcomes, and the trim and fill method reduced the
confidence intervals of ES estimates for self-reported between-
groups outcomes to below zero. Nevertheless, the capacity to
detect bias is limited when meta-analyses are based on a limited
number of small trials; therefore, the results from these analyses
should be treated with considerable caution (Egger et al., 1997).
For example, when there are fewer than 10 studies the power
of Egger’s test is insufficient to distinguish chance from genuine
asymmetry (Higgins andGreen, 2011). Fourth, the generalization
of the findings is limited by the high levels of heterogeneity
among the studies included. Fifth, the small number of MBCT
and biofeedback studies included in this review (only one of each
type of study) limits the interpretation of the results concerning
these therapies. Sixth, the high level of attrition observed (36.6%)
is a concern, since greater than 20% loss potentially threatens
study validity (Schulz and Grimes, 2002). Seventh, it should
be noted that the results of the moderator analyses must be
interpreted with extreme caution because of the small sample
size.
The use of larger samples, multi-center studies, specification
of the pharmacological condition, inclusion of a proper
comparison group (if possible an active control group),
use of independent blinded outcome sources, accurate
detailing of attrition (with intent-to-treat analyses) and
the allocation/randomization process, and evaluation of
maintenance of long-term gains should be addressed by future
research to improve the internal validity of findings.
Furthermore, some relevant questions remain unresolved.
To improve the efficiency of treatment, further research should
be carried out to establish the specific weight of each therapy
component in overall efficacy (e.g., organizing and planning
skills, skills to reduce distractibility, cognitive restructuring,
behavior analysis, and impulse control, among others). Given
the heterogeneous nature of ADHD, it will be important
to determine whether different psychosocial interventions (or
therapy ingredients) may be specifically effective for each of
its symptom dimensions (e.g., inattention, hyperactivity, and
impulsivity). In addition, future research could explore the
characteristics of adults with ADHD who are more likely to
respond to CBT therapies. Previous studies have found that
adding a psychosocial intervention improves the effects of
pharmacological treatment (Safren et al., 2005; Emilsson et al.,
2011; Young et al., 2015); however, more research is needed
to determine whether the opposite is true. While some studies
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FIGURE 13 | Forest plot for within-subject global functioning outcome.
have found that adding medication to psychological therapy
did not significantly improve outcomes (Weiss et al., 2012),
others concluded that a combination of methylphenidate and
psychotherapy is significantly more effective than psychotherapy
alone (Philipsen et al., 2015; Cherkasova et al., 2016). Although it
requires further investigation, some studies have demonstrated
the preliminary efficacy and feasibility of the use of CBT
alone (without medication) (Ramsay and Rostain, 2011; Ramsay,
2012), which would be especially useful in those, not uncommon,
cases in which medication is not tolerated or is ineffective.
Treatment guidelines state that psychological interventions
without medication may be effective for some adults with
moderate impairment; however, there are insufficient data to
support this recommendation (National Institute for Health and
Care Excellence, 2008).
CONCLUSIONS
Psychosocial treatments are effective for treatment of ADHD
at the end of the intervention and the gains are sustained for
up to 12 months. In the long term, psychosocial interventions,
particularly CBT, are effective in improving self-rated inattention,
hyperactivity/impulsivity, and total ADHD symptoms, together
with CGI and global functioning, in comparisons with control
groups. Within-subject improvements were also significant when
rated by blind assessors. However, a careful interpretation of
these data is necessary because of the high level of heterogeneity
and high risk of bias determined for many of the outcomes. There
remain many important questions to be addressed by future
studies; however, the evidence from this review suggests that
psychological interventions are highly valuable and stable clinical
tools for the treatment of adults with ADHD.
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